Yubo International Biotech Ltd Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Yubo International Biotech Ltd quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
  • Yubo International Biotech Ltd Debt-to-equity for the quarter ending June 30, 2024 was -189 %, a 54.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -189 +226 +54.4% Jun 30, 2024
Q1 2024 -215 +254 +54.2% Mar 31, 2024
Q4 2023 -255 +296 +53.7% Dec 31, 2023
Q3 2023 -328 +373 +53.2% Sep 30, 2023
Q2 2023 -416 +593 +58.8% Jun 30, 2023
Q1 2023 -469 +17.3K +97.4% Mar 31, 2023
Q4 2022 -551 -1.52K -157% Dec 31, 2022
Q3 2022 -701 -1.12K -269% Sep 30, 2022
Q2 2022 -1.01K Jun 30, 2022
Q1 2022 -17.8K Mar 31, 2022
Q4 2021 973 Dec 31, 2021
Q3 2021 416 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.